In The News Posted November 13, 2021 Share Posted November 13, 2021 SAN DIEGO, Nov. 13, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of: (1) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with Silverback Therapeutics' initial...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now